Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Not Yet Recruiting

This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT06427213

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)

NCT06416267

Conditions: Alzheimer Disease, Autoimmune Diseases, Basal Ganglia Diseases, +33 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Biological and Clinical Efficacy of Shingrix in Patients With CLL

NCT06364033

Conditions: CLL-like MBL, Chronic Disease, Chronic Lymphocytic Leukemia, +17 more
Locations: UOC Ematologia ASST dei Sette Laghi Varese, Italy

View Trial Details

Not Yet Recruiting

Familial B-cell Lymphoproliferative Disorders

NCT05718986

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma

NCT06368167

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL

NCT06367374

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Maintenance Hormonal Therapy and DLBCL

NCT06355401

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma

NCT06318884

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Henan Cancer Hospital Zhengzhou, Henan, China

Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.

NCT06324994

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The Second Hospital Dalian Medical University Dalian, Liaoning, China

View Trial Details

Not Yet Recruiting

A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL

NCT06314828

Conditions: B-cell Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions